Case Report: Persistent severe thrombocytopenia after adjuvant ado-trastuzumab emtansine with sequential bone marrow findings and romiplostim support - Scorecard - MDSpire

Case Report: Persistent severe thrombocytopenia after adjuvant ado-trastuzumab emtansine with sequential bone marrow findings and romiplostim support

  • By

  • Dan Qiao

  • Lei Nie

  • Shuang Liu

  • Hai-bin Ding

  • June 17, 2026

  • 0 min

Share

Clinical Scorecard: Case Study: Prolonged Severe Thrombocytopenia Following Adjuvant Ado-Trastuzumab Emtansine with Sequential Bone Marrow Evaluations and Romiplostim Intervention

At a Glance

CategoryDetail
Condition
Key MechanismsImpairment of megakaryocyte differentiation and platelet production (source needed).
Target Population
Care Setting

Key Highlights

  • Remove unsupported claims.

Guideline-Based Recommendations

Diagnosis

    Management

    • Consider romiplostim for long-term stabilization of platelet counts (source needed).

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Postmenopausal women with HER2-positive early breast cancer

        Thrombocytopenia may develop after T-DM1, requiring careful management.

        Clinical Best Practices

        • Remove unsupported practices.

        Related Resources & Content

        Original Source(s)

        Case Report: Persistent severe thrombocytopenia after adjuvant ado-trastuzumab emtansine with sequential bone marrow findings and romiplostim support

        • by Dan Qiao, Lei Nie, Shuang Liu, Hai-bin Ding

        • June 17, 2026

        Related Content

        Bulk and single-cell RNA sequencing data identified HMGB3 of chromatin regulators as a breast cancer biomarker associated with the cell cycle

        Development and validation of an interpretable machine learning model for predicting 5-year recurrence in breast cancer

        Vaginal microbiota and genitourinary syndrome of menopause in premenopausal breast cancer patients receiving endocrine therapy: a longitudinal cohort study protocol